	Prognostic value of neutrophil to lymphocyte ratio for patients with bladder cancer undergoing radical cystectomy: a systematic review and meta-analysis. Front Oncol Chen Z, Zhang Y, Chen T. PMID: 39507758 [PubMed]
	Prognostic value of neutrophil-to-lymphocyte ratio in patients with non-muscle-invasive bladder cancer with intravesical Bacillus Calmette-GuÃ©rin immunotherapy: a systematic review and meta-analysis. Front Immunol Huang J, Lin L, Mao D, Hua R, Guan F. PMID: 39507536 [PubMed - indexed for MEDLINE]
	Analysis of Wilms Tumour Epidemiology, Clinicopathological Features and Treatment Outcomes in 84 Moroccan Patients. Cancer Rep (Hoboken) Benlhachemi S, Khattab M, Hattoufi K, Abouqal R, Boutayeb S, El Fahime E. PMID: 39506861 [PubMed - indexed for MEDLINE]
	MicroRNA in prostate cancer: from biogenesis to applicative potential. BMC Urol Luo X, Wen W. PMID: 39506720 [PubMed - indexed for MEDLINE]
	[Prostate cancer screening : to be recommended in 2024?]. Rev Med Suisse Bosshart A, Bacchetta F, Boesch A, Durand MA, Valerio M, Selby K. PMID: 39506475 [PubMed - indexed for MEDLINE]
	The impact of progression-directed therapy on survival in metastatic castration-refractory prostate cancer: MEDCARE phase 3 trial. BJU Int Rans K, Goffin K, Joniau S, Daugaard G, den Hartog J, Van Wynsberge L, De Meerleer G. PMID: 39506181 [PubMed - as supplied by publisher]
	Comprehensive review of cardiovascular disease in prostate cancer: epidemiology, risk factors, therapeutics and prevention strategies. Prostate Cancer Prostatic Dis Moryousef J, Duivenvoorden W, Leong D, Pinthus JH. PMID: 39506079 [PubMed - as supplied by publisher]
	Impact of renal impairment on early development of severe neutropenia with trifluridine/tipiracil treatment for metastatic colorectal cancer. Sci Rep Saito Y, Takekuma Y, Komatsu Y, Sugawara M. PMID: 39506021 [PubMed - indexed for MEDLINE]
	[Small renal mass: which criteria are decisive for a tumor board?]. Urologie Dräger DL, Rojas Cruz C, Held J, Niepel F, Zimpfer A, Hakenberg OW. PMID: 39505775 [PubMed - as supplied by publisher]
	First and Second-line Treatments in Metastatic Renal Cell Carcinoma. Eur Urol Barragan-Carrillo R, Saad E, Saliby RM, Sun M, Albiges L, Bex A, Heng D, Mejean A, Motzer RJ, Plimack ER, Powles T, Rini BI, Zhang T, Choueiri TK. PMID: 39505582 [PubMed - as supplied by publisher]
	Association between soy products and prostate cancer: A systematic review and meta-analysis of observational studies. Investig Clin Urol Huang Y, Wang W, Jin J. PMID: 39505513 [PubMed - indexed for MEDLINE]
	Prostate cancer theragnostics biomarkers: An update. Investig Clin Urol Kumar Am S, Rajan P, Alkhamees M, Holley M, Lakshmanan VK. PMID: 39505512 [PubMed - indexed for MEDLINE]
	The Current Status of Comprehensive Genomic Profiling in the Management of Metastatic Castration-Resistant Prostate Cancer: A Study from a Cooperative Hospital for Cancer Genomic Medicine in Japan. J Nippon Med Sch Akatsuka J, Kimura G, Takadate M, Hiraoka S, Sahara T, Iwai T, Hasegawa H, Mikami H, Obayashi K, Takeda H, Endo Y, Toyama Y, Yamamoto Y, Yamada T, Kondo Y. PMID: 39505505 [PubMed - indexed for MEDLINE]
	A Randomized Controlled Trial of Gamification to Increase Physical Activity Among Black and Hispanic Breast and Prostate Cancer Survivors: Rationale and Design of the ALLSTAR Clinical Trial. Am Heart J Fanaroff AC, Orr JA, Anucha C, Kim E, Rareshide C, Echevarria M, Rodarte S, Kassabian M, Balasian E, Ky B, Volpp KGM, Armenian S. PMID: 39505121 [PubMed - as supplied by publisher]
	Global trends and projections of occupational trichloroethylene (TCE) exposure-associated kidney cancer: Insights of the Global Burden of Disease (GBD) Study 2021 from 1990 to 2021 and prediction to 2050. Ecotoxicol Environ Saf Huang H, Li P, Jiang H, Hong J, Lu Y. PMID: 39504875 [PubMed - as supplied by publisher]
	Association of viral infection with bladder cancer: A systematic review and meta-analysis. Pathol Res Pract Motlaghzadeh S, Tabatabaei F, Eshragh F, Tavakoli A, Mobasheri N, Kiani SJ, Saadati H, Asli S, Chegeni AM, Letafati A, Khatami A, Hosseini M, Salavatiha Z, Babaei A, Fakheri Sueini V, Asadi D, Keyvanlou Z, Maskouni EJ, Bahavar A, Sorouri Majd M, Esfandiari AH, Khazaee H, Soleymani P, Shahamiri K, Moazamiyanfar R, Shirazi SB, Hafezi A, Zarei M, Khalesi Z, Ghorbani S. PMID: 39504615 [PubMed - as supplied by publisher]
	Phase II trial of multi-tyrosine kinase inhibitor ESK981 in combination with PD-1 inhibitor nivolumab in patients with metastatic castration-resistant prostate cancer. Invest New Drugs Heath EI, Chen W, Choi JE, Dobson K, Smith M, Maj T, Kryczek I, Zou W, Chinnaiyan AM, Qiao Y. PMID: 39503807 [PubMed - as supplied by publisher]
	Ideal cystoscopic interval after nephroureterectomy in patients with upper tract urothelial carcinoma. World J Urol Konta S, Hashimoto K, Shindo T, Kobayashi K, Tanaka T, Masumori N. PMID: 39503753 [PubMed - indexed for MEDLINE]
	The role of re-transurethral resection of bladder tumor in patients with TaHG non muscle invasive bladder cancer. World J Urol Scilipoti P, Moschini M, de Angelis M, Afferi L, Lonati C, Longoni M, Tremolada G, Zaurito P, Viti A, Santangelo A, Pichler R, Necchi A, Montorsi F, Briganti A, Mari A, Krajewski W, Laukthina E, Pradere B, Del Giudice F, Mertens L, Gallioli A, Soria F, Gontero P, Albisinni S, Shariat SF, Carando R, European Association of Urology-Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group. PMID: 39503747 [PubMed - indexed for MEDLINE]
	Multidimensional Healthcare Access Barriers to Prostate-Specific Antigen Testing: A Nation-Wide Panel Study in the United States From 2006 to 2020. Cancer Med Iyer HS, Kensler KH, Roscoe C, Opara C, He M, Kovac E, Garraway IP, Dien-Trinh Q, Rebbeck TR. PMID: 39503193 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 162985

Page 1 of 8150



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy